| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2010 | EP2182951A2 Treatment of pediatric tumors |
| 05/12/2010 | EP2182950A1 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
| 05/12/2010 | EP2182948A1 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 05/12/2010 | EP2182946A1 Substituted azabicyclo [4.1.0]heptane compounds for use as monoamine reuptake inhibitors |
| 05/12/2010 | EP2182945A1 Animal pest control method |
| 05/12/2010 | EP2182943A2 Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
| 05/12/2010 | EP2182942A1 Pharmaceutical composition effective against biofilms |
| 05/12/2010 | EP2182941A2 Multikinase inhibitors for use in the treatment of cancer |
| 05/12/2010 | EP2182940A1 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease |
| 05/12/2010 | EP2182939A2 Compositions including triciribine and taxanes and methods of use thereof |
| 05/12/2010 | EP2182938A2 Methods for promoting wakefulness |
| 05/12/2010 | EP2182937A2 An antiviral composition |
| 05/12/2010 | EP2182936A2 Substrate reduction therapy |
| 05/12/2010 | EP2182935A1 The use of benzamide derivatives for the treatment of cns disorders |
| 05/12/2010 | EP2182934A1 Uses of trientine and penicillamine as countermeasures to metal contamination |
| 05/12/2010 | EP2182932A2 Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine |
| 05/12/2010 | EP2182929A2 Duloxetine formulations |
| 05/12/2010 | EP2182927A2 Pharmaceutical compositions of candesartan |
| 05/12/2010 | EP2182926A2 Anti-hiv tablet formulations comprising darunavir |
| 05/12/2010 | EP2182921A2 Medicament for transdermal use on animals |
| 05/12/2010 | EP2182920A2 Stable liquid pharmaceutical composition based on trazodone |
| 05/12/2010 | EP2182918A2 Pharmaceutical composition for topical application of poorly soluble compounds |
| 05/12/2010 | EP2182917A1 A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor |
| 05/12/2010 | EP2182902A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 05/12/2010 | EP2182810A2 Compositions and methods for treatment and prevention of osteoarthritis |
| 05/12/2010 | EP2182809A1 Therapeutic isoxazole compounds |
| 05/12/2010 | EP2182808A1 Pyridine compounds for inflammation and immune-related uses |
| 05/12/2010 | EP2182807A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 05/12/2010 | EP2182805A2 Antiviral drugs for treatment of arenavirus infection |
| 05/12/2010 | EP2182804A1 Methods for treating dependence |
| 05/12/2010 | EP2182803A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder |
| 05/12/2010 | EP2182801A1 Pyrone analog compositions and methods |
| 05/12/2010 | EP2099762B1 Antibacterial quinoline derivatives |
| 05/12/2010 | EP2078001B1 Diazepane-acetamide derivatives as selective 11 -hsd1 inhibitors |
| 05/12/2010 | EP2076499B1 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/12/2010 | EP2069342B1 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 05/12/2010 | EP2066318B1 Oxindole derivatives as anticancer agents |
| 05/12/2010 | EP2049519B1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/12/2010 | EP2032574B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/12/2010 | EP2002018B1 Antisense antiviral compound and method for treating arenavirus infection |
| 05/12/2010 | EP1971605B1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators |
| 05/12/2010 | EP1899350B1 Pyrazolo [3 , 4-d]azepine derivatives as histamine h3 antagonists |
| 05/12/2010 | EP1899343B1 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates |
| 05/12/2010 | EP1870409B1 Benzimidazole compounds |
| 05/12/2010 | EP1828113B1 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses |
| 05/12/2010 | EP1711187B1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/12/2010 | EP1706489B1 Oligomeric compounds for the modulation of bcl-2 |
| 05/12/2010 | EP1663219B1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 05/12/2010 | EP1644397B1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 05/12/2010 | EP1603606B1 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative |
| 05/12/2010 | EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 05/12/2010 | EP1519933B1 Quinuclidine amide derivatives |
| 05/12/2010 | EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 05/12/2010 | EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/12/2010 | DE202007019054U1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof |
| 05/12/2010 | DE202007019049U1 Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption Use of a progestin in combination with an estrogen for prevention of lactose intolerance in oral contraception |
| 05/12/2010 | DE102008057230A1 Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin Synergistic pharmaceutical combination with an estrogen receptor antagonist and a progestin |
| 05/12/2010 | CN201453685U Enteric-coated capsule of piperazine ferulate |
| 05/12/2010 | CN201453684U Enteric-coated capsule of sodium ferulate |
| 05/12/2010 | CN1994345B Compound Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 05/12/2010 | CN1994307B Compound transdermal drug-delivery preparation for preventing intoxication of organophosphorus ester compound |
| 05/12/2010 | CN1993350B Salt of benzimidazole derivative with amine, and process for producing the same |
| 05/12/2010 | CN1989139B Benzothiazole derivatives |
| 05/12/2010 | CN1985987B Medicine composition of glycyrrhizic acid or its salt and reduced glutathione |
| 05/12/2010 | CN1985883B Antifungal medicine composition and its preparing method and use |
| 05/12/2010 | CN1985843B Malaria treating medicine |
| 05/12/2010 | CN1973839B Nizatidine injection |
| 05/12/2010 | CN1973836B Hydrophilic plaster for treating dysmenorrhea |
| 05/12/2010 | CN1973832B Biodegradable nanometer medicine capsule with CT trace effect and its preparation process |
| 05/12/2010 | CN1966021B Bone-setting pill |
| 05/12/2010 | CN1965958B Remedy for treating burn and scald |
| 05/12/2010 | CN1965907B Chinese medicinal spray for preventing and treating cold and method for preparing same |
| 05/12/2010 | CN1965874B Preparation of total aglycone of india pokeberry and application thereof in cough-relieving sputum-resolving medicament |
| 05/12/2010 | CN1965823B (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione, its preparation method and its compound |
| 05/12/2010 | CN1965813B Compound soft capsule of propolis |
| 05/12/2010 | CN1961962B Amphiphilic tri-block copolymer taxol bonding medicament and synthesis method thereof |
| 05/12/2010 | CN1961895B A novel anticancer pharmaceutical composition and preparation method thereof |
| 05/12/2010 | CN1960984B Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists |
| 05/12/2010 | CN1944424B Aryl formyl piperazine compound and its preparing method and use in medicine production |
| 05/12/2010 | CN1943606B Chinese angelica root extract for treating cancer |
| 05/12/2010 | CN1943584B Medicinal composition for treating cardio-cerebral vascular disease and its preparing method |
| 05/12/2010 | CN1943569B Chinese medicine active component composition and its preparing method and use |
| 05/12/2010 | CN1939895B Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 05/12/2010 | CN1938319B Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same |
| 05/12/2010 | CN1938048B Liposome preparation |
| 05/12/2010 | CN1933853B Drug conjugates |
| 05/12/2010 | CN1931247B Medicine for treating rhinitis and its preparation process |
| 05/12/2010 | CN1931159B Superfine Iguratimod powder and quick released oral preparation |
| 05/12/2010 | CN1929850B Purified polyoxypropylene/polyoxyethylene copolymers and method of preparing the same |
| 05/12/2010 | CN1927050B DHA microcapsule food additives, DHA soft capsule health product and uses thereof |
| 05/12/2010 | CN1916064B Dry powder of gelatinous polysaccharide of aloe, producing method and preparation |
| 05/12/2010 | CN1916030B Highly sulfated derivatives of k5 polysaccharide and their preparation |
| 05/12/2010 | CN1915992B Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 05/12/2010 | CN1907979B 8-methylene-methylamine-5,7-dihydroxy-6,4'-dimethoxyisoflavone and medicinal composition with the same as active component |
| 05/12/2010 | CN1907371B Chinese patent medicine for treating anus cryptitis and hemorrhoid |
| 05/12/2010 | CN1903308B Active position of Omithogalum caudatum ait, its preparation method, medicine and application thereof |
| 05/12/2010 | CN1903252B Fingerprint analysis method for traditional Chinese medicine composition to treat cardiovascular disease |
| 05/12/2010 | CN1899400B Detection method for injection containing ginseng and aconite root in raw material |
| 05/12/2010 | CN1899392B Chinese medicine composition for treating gynecological inflammation and its preparing method and use |
| 05/12/2010 | CN1899389B Medicinal composition for preventing and treating female senile diseases and method for preparing said preparation |